Assembly Biosciences (ASMB) EBITDA (2010 - 2026)
Assembly Biosciences (ASMB) recorded quarterly EBITDA of -$9.4 million in Q1 2026, down 142.49% quarter-over-quarter from $22.1 million in Q4 2025, and down 6.16% on a YoY basis from -$10.0 million in Q1 2025.
Assembly Biosciences (ASMB) EBITDA (2010 - 2026) Analysis & Trends
Assembly Biosciences' EBITDA history runs 17 years deep, the most recent figure standing at -$9.4 million for Q1 2026.
- In Q1 2026, EBITDA fell 6.16% year-over-year to -$9.4 million; the TTM figure through Mar 2026 stood at -$6.5 million (up 83.73% YoY), while the FY2025 annual figure was -$6.0 million, up 85.23% from the prior year.
- EBITDA was -$9.4 million for Q1 2026 at Assembly Biosciences, down from $22.1 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of $22.1 million in Q4 2025 to a low of -$24.6 million in Q2 2022.
- Historically, EBITDA has averaged -$12.3 million across 5 years, with a median of -$10.8 million in 2023.
- The sharpest annual moves came in 2022 and 2025: EBITDA fell 23.0% in 2022, then jumped 313.08% in 2025.
- A 5-year view of EBITDA shows it stood at -$22.2 million in 2022, then jumped by 51.49% to -$10.8 million in 2023, then advanced by 3.51% to -$10.4 million in 2024, then jumped by 313.08% to $22.1 million in 2025, then sank by 142.49% to -$9.4 million in 2026.
- The last three EBITDA figures came in at -$9.4 million (Q1 2026), $22.1 million (Q4 2025), and -$9.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Assembly Biosciences | 418.96 Mn | 192.36 Mn | - | -9.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.41 Mn |
| Dec 31, 2025 | 22.14 Mn |
| Sep 30, 2025 | -9.01 Mn |
| Jun 30, 2025 | -10.22 Mn |
| Mar 31, 2025 | -8.86 Mn |
| Dec 31, 2024 | -10.39 Mn |
| Sep 30, 2024 | -9.48 Mn |
| Jun 30, 2024 | -11.21 Mn |
| Mar 31, 2024 | -9.24 Mn |
| Dec 31, 2023 | -10.77 Mn |
| Sep 30, 2023 | -14.37 Mn |
| Jun 30, 2023 | -16.71 Mn |
| Mar 31, 2023 | -18.66 Mn |
| Dec 31, 2022 | -22.20 Mn |
| Sep 30, 2022 | -23.15 Mn |
| Jun 30, 2022 | -24.55 Mn |
| Mar 31, 2022 | -23.58 Mn |
| Dec 31, 2021 | -60.39 Mn |
| Sep 30, 2021 | -18.82 Mn |
| Jun 30, 2021 | -23.60 Mn |